Simultaneous quantification of 24 antiepileptic drugs from plasma or serum by LC-MS/MS for therapeutic drug monitoring.
This comprehensive panel enables simultaneous monitoring of 24 antiepileptic drugs, supporting optimisation of seizure control while minimising adverse effects through individualised dosing.
Clinical indications include:
24 antiepileptic drugs including carbamazepine, oxcarbazepine, lamotrigine, valproic acid, phenytoin, phenobarbital, levetiracetam, topiramate, lacosamide, zonisamide, clobazam, clonazepam, and others.
All 24 drugs are quantified simultaneously by LC-MS/MS from a single plasma or serum sample, using stable isotope internal standards for each analyte. The method provides the specificity necessary to avoid cross-reactivity between structurally similar drugs and their metabolites.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.